Omeros (OMER) Receivables - Other (2011 - 2026)
Omeros (OMER) reported Receivables - Other of $92000.0 for Q1 2026, down 93.65% on a YoY basis from $1.4 million in Q1 2025, and down 87.73% sequentially from $750000.0 in Q4 2025.
Omeros (OMER) Receivables - Other (2011 - 2026) Analysis & Trends
Omeros (OMER) has 16 years of Receivables - Other data on file, last reported at $92000.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Other fell 93.65% year-over-year to $92000.0; the trailing twelve-month figure through Mar 2026 stood at $92000.0 (down 93.65% YoY), and the FY2025 full-year result was $750000.0, down 6.13% from the prior year.
- Receivables - Other retreated to $92000.0 in Q1 2026, from $750000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $1.4 million in Q1 2025 to a low of $92000.0 in Q1 2026.
- A 5-year average of $675235.3 and a median of $741000.0 in 2022 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other jumped 927.42% in 2024 and tumbled 93.65% in 2026, its largest moves.
- Tracing OMER's Receivables - Other over 5 years: stood at $255000.0 in 2022, then jumped by 438.04% to $1.4 million in 2023, then plunged by 41.76% to $799000.0 in 2024, then slipped by 6.13% to $750000.0 in 2025, then tumbled by 87.73% to $92000.0 in 2026.
- Business Quant data shows OMER's Receivables - Other at $92000.0 in Q1 2026, $750000.0 in Q4 2025, and $863000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92,000.00 |
| Mar 31, 2026 | 92,000.00 |
| Dec 31, 2025 | 750,000.00 |
| Dec 31, 2025 | 750,000.00 |
| Sep 30, 2025 | 863,000.00 |
| Sep 30, 2025 | 863,000.00 |
| Jun 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.45 Mn |
| Mar 31, 2025 | 1.45 Mn |
| Dec 31, 2024 | 799,000.00 |
| Dec 31, 2024 | 799,000.00 |
| Sep 30, 2024 | 299,000.00 |
| Sep 30, 2024 | 299,000.00 |
| Jun 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 656,000.00 |
| Mar 31, 2024 | 656,000.00 |
| Dec 31, 2023 | 1.37 Mn |
| Dec 31, 2023 | 1.37 Mn |